메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Lee Su Chul (Novel Drug Research Center HK inno.N Corp.) Kim Myeongjoong (Novel Drug Research Center HK inno.N Corp.) Kim Donghyun (Novel Drug Research Center HK inno.N Corp.) 전은경 (에이치케이이노엔(주)) 이은희 (고려대학교)
저널정보
한국약제학회 Journal of Pharmaceutical Investigation Journal of Pharmaceutical Investigation 제52권 제5호
발행연도
2022.9
수록면
623 - 638 (16page)
DOI
10.1007/s40005-022-00582-y

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose The purpose of this study was to develop a patient-centric formulation of tegoprazan, a novel potassium-competitive acid blocker, using modified-release drug-coated pellets. Methods Tegoprazan tablets, sustained-release (SR) polymer-coated pellets, SR drug-coated pellets, enteric-coated (DR) pellets, SR polymer-coated pellets with an enteric coating (CR1), SR drug-coated pellets with an enteric coating (CR2), and tegoprazan immediate-release (IR) powder were prepared. Dual-release capsules were prepared by combining the IR powder with the CR1, CR2, and DR pellets (IR/CR1, IR/CR2, and IR/DR, respectively). In vitro dissolution tests were conducted to screen the formulations, and in vivo pharmacokinetic (PK) analysis was conducted using cynomolgus monkeys. Design of experiments was employed to optimize the formulation for the CR2 pellets. The effect of the particle size on the dissolution profile of the CR2 pellets was investigated using scanning electron microscopy. Results In vitro dissolution of the IR/CR1 capsule produced the desired pH- and time-dependent release profile, and in vivo PK analysis confirmed that drug absorption was well-controlled by this formulation. The IR/CR2 capsule exhibited a pHand time-dependent release of tegoprazan that was similar to that of the IR/CR1 capsule. Small drug particles appeared to become embedded in the densely packed coating, thus dissolving more slowly than the medium and large drug particles. Conclusion Unlike the CR1 pellets, the CR2 pellets did not require an additional coating and curing process. The developed IR/CR2 capsule is also expected to prevent nocturnal acid breakthrough and thus improve patient compliance.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0